ISCD Learning
Catalog Advanced Search
-
ASRT Category A Credits
Expires 12/1/2027: This session will provide DXA technologists with a comprehensive review of quality assurance and troubleshooting principles essential for maintaining accurate and reproducible bone density measurements. Participants will examine routine quality-control practices, including the use of control charts, the establishment of action limits, and criteria for determining when manufacturer service intervention is required. The program will also focus on applying least significant change (LSC) values derived from precision studies to accurately assess longitudinal changes in bone mineral density. In addition, participants will examine differences among DXA scanners and software platforms, emphasizing the critical role of cross-calibration in ensuring valid clinical interpretation and continuity of patient care when comparing measurements across systems.
Activity approved for 1.5 ASRT Category A Credits
Activity Expires December 1, 2027Activity Description
This session will provide DXA technologists with a comprehensive review of quality assurance and troubleshooting principles essential for maintaining accurate and reproducible bone density measurements. Participants will examine routine quality-control practices, including the use of control charts, the establishment of action limits, and criteria for determining when manufacturer service intervention is required. The program will also focus on applying least significant change (LSC) values derived from precision studies to accurately assess longitudinal changes in bone mineral density. In addition, participants will examine differences among DXA scanners and software platforms, emphasizing the critical role of cross-calibration in ensuring valid clinical interpretation and continuity of patient care when comparing measurements across systems.
Learning Objectives
- Describe general quality assurance and troubleshooting principles, including the use of control charts, setting action limits, and determining when service intervention is required.
- Implement least significant change (LSC) values derived from precision studies to assess longitudinal changes in bone density.
- Discuss scanner differences and the importance of cross-calibration when comparing measurements across systems.
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.ASRT Credit Designation
This activity has been approved by ASRT for 1.5 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on November 15th, 2026.
$i++ ?>Lawrence Jankowski, CBDT
Chief DXA Technologist/Research Coordinator
Illinois Bone and Joint Institute, LLC
Lawrence Jankowski is the chief DXA technologist and a research coordinator for Illinois Bone and Joint Institute, a multi-disciplinary 100+ physician practice with over 20 locations within Chicago and surrounding suburbs, specializing in orthopedic and rheumatologic health and sports performance and fitness. He started clinical imaging as a nuclear medicine technologist in 1978, performing both single- and dual- photon absorptiometry in beginning in 1987, and switched to DXA in 1990. He is also registered in radiology (limited), and is certified by the International Society for Clinical Densitometry (ISCD) first as a CDT in 1996, and then CBDT in 2001.
In addition to his clinical and research duties, he is a technical instructor for the ISCD bone density courses, serves on the editorial board for the Journal of Clinical Densitometry, chairman of the Facility Accreditation Program, He has presented numerous posters on bone densitometry at scientific meetings, including the ASBMR, AAOS, NOF, as well as ISCD. Most recently, he served as task force chair for the 2019 Position Development Conference on cross-calibration and LSC determination in multiple scanner environments.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to [email protected]. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - $25
- Clinician Member - $25
- Technologist Member - $25
- Resident/Student/Fellow/Retired Membership - $25
- MOC Only - $35
- Community Member - $35
- Professional Member - $35
- More Information
-
Both ACCME and ASRT Credits
Expires 12/1/2027: This session will provide DXA technologists with a structured review of selected peer-reviewed articles addressing key aspects of DXA practice, including quality assurance, patient positioning, clinical applications, software innovation, and technologist–patient communication. Participants will examine the purpose, methodology, and principal findings of each article and discuss their relevance to the daily technologist workflow, scan quality, and patient care. The program will also highlight the broader significance of these research findings and explore their potential impact on the evolving role of current and future DXA technologists, supporting evidence-based practice and professional development.
Activity approved for 1.00 ASRT Category A Credits
Activity Expires December 1, 2027Activity Description
This session will provide DXA technologists with a structured review of selected peer-reviewed articles addressing key aspects of DXA practice, including quality assurance, patient positioning, clinical applications, software innovation, and technologist–patient communication. Participants will examine the purpose, methodology, and principal findings of each article and discuss their relevance to the daily technologist workflow, scan quality, and patient care. The program will also highlight the broader significance of these research findings and explore their potential impact on the evolving role of current and future DXA technologists, supporting evidence-based practice and professional development.
Learning Objectives
- Describe the purpose, methods, and key findings of each selected article, highlighting implications for technologist positioning practices, clinical applications of DXA, and software and workflow innovations and limitations.
- Discuss how the reported findings relate to DXA technologist workflow, including effects on scan acquisition steps, image quality, interpretation support, and downstream patient care.
- Explain the significance of this body of literature for current and future DXA technologists, focusing on how the evidence can inform practice standards, training priorities, and the evolution of technologist roles in patient-centered bone health and body composition assessment.
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.ASRT Credit Designation
This activity has been approved by ASRT for 1.00 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on November 15th, 2026.
$i++ ?>Christopher Cirnigliaro, PhD, CBDT
Investigator
James J. Peters VA Medical Center
For more than 24 years, Dr. Christopher M. Cirnigliaro has served as an investigator and bone densitometry technician at the James J. Peters VA Medical Center Spinal Cord Damage Research Center. His primary research interests focus on the diagnosis, prevention, and treatment of bone loss in individuals living with acute and chronic spinal cord injury. Over the course of his career, Dr. Cirnigliaro has been a co-investigator on more than ten clinical trials examining post-injury bone loss. He has served as senior research coordinator and co-investigator on multiple studies involving the bisphosphonates pamidronate and zoledronic acid, as well as two recent trials combining the RANKL inhibitor denosumab with the anti-sclerostin agent romosozumab to prevent and treat bone loss following spinal cord injury. In all of these studies, Dr. Cirnigliaro has developed protocol designs for image acquisition and analysis, and has led statistical analyses of bone mineral density data derived from dual-energy X-ray absorptiometry (DXA) and peripheral quantitative computed tomography (pQCT). Dr. Cirnigliaro is currently a recipient of the VA Rehabilitation Research and Development & Translation Career Development Award-2. His ongoing research investigates the effects of exoskeleton-assisted walking and transcutaneous spinal cord stimulation on imaging and serum biomarkers of skeletal muscle mass and bone strength in individuals with chronic spinal cord injury.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to [email protected]. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - Free!
- Clinician Member - Free!
- Technologist Member - Free!
- Resident/Student/Fellow/Retired Membership - Free!
- MOC Only - Free!
- Community Member - $35
- Professional Member - Free!
- More Information
-
Both ACCME and ASRT Credits
Expires 12/1/2027: This session is designed to advance DXA technologists' expertise in scan acquisition, evaluation, and quality assurance in complex imaging scenarios. Using anonymized cases from the ISCD atlas, participants will learn to identify examinations compromised by challenging anatomy or patient-related factors that render scans diagnostically non-evaluable. The program will provide detailed instruction on recognizing technical acquisition and analysis errors that require repeat imaging, including manufacturer-specific and cross-platform artifacts, and will outline appropriate corrective actions to optimize scan quality. Additionally, the session will review protocol modifications and positioning strategies for patients with implants, scoliosis, and degenerative changes, as well as technical considerations for special populations, including pediatric and obese patients, to ensure accurate, reproducible bone density measurements.
Activity approved for 1.5 ASRT Category A Credits
Activity Expires December 1, 2027Activity Description
This session is designed to advance DXA technologists' expertise in scan acquisition, evaluation, and quality assurance in complex imaging scenarios. Using anonymized cases from the ISCD atlas, participants will learn to identify examinations compromised by challenging anatomy or patient-related factors that render scans diagnostically non-evaluable. The program will provide detailed instruction on recognizing technical acquisition and analysis errors that require repeat imaging, including manufacturer-specific and cross-platform artifacts, and will outline appropriate corrective actions to optimize scan quality. Additionally, the session will review protocol modifications and positioning strategies for patients with implants, scoliosis, and degenerative changes, as well as technical considerations for special populations, including pediatric and obese patients, to ensure accurate, reproducible bone density measurements.
Learning Objectives
- Identify DXA scans with challenging anatomy or patient-related factors that render them no longer diagnostically evaluable, using anonymized cases from the ISCD atlas.
- Recognize technical scan failures that require repeat imaging and describe appropriate corrective actions, including identification of common artifacts across manufacturers, using anonymized cases from the ISCD atlas.
- Discuss protocol modifications for patients with implants, scoliosis, degenerative changes, and special populations including pediatric and obese patients.
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.ASRT Credit Designation
This activity has been approved by ASRT for 1.5 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on November 15th, 2026.
$i++ ?>Orhan K. Oz, MD, PhD, CCD
Professor of Radiology, Chief of Nuclear Medicine
UT Southwestern Medical Center
Orhan K. Öz, M.D., Ph.D., is Professor of Radiology and Division Chief of Nuclear Medicine, Department of Radiology at UT Southwestern Medical Center. He is holder of the Robert W. Parkey, MD Distinguished Professorship in Radiology and Wechu Pak Professorship in Bone Biophysics. He also holds a secondary appointment in the Charles and Jane Pak Center for Mineral Metabolism and Clinical Research. Additionally, Dr. Öz serves as Medical Director of Nuclear Medicine at Clements University Hospital and directs the UT Southwestern Nuclear Medicine Residency program. His clinical interests include diagnostic and therapeutic nuclear medicine, general radiology, imaging in metabolic bone disease and infection imaging, particularly diabetic foot infections.
Dr. Öz holds a bachelor’s degree in biology, chemistry, and mathematics from Morehouse College in Atlanta, and a master’s degree in applied mathematics from Clark Atlanta University. After receiving his medical degree and doctoral degree in biophysics from Stanford University, he completed his residency training in radiology at UT Southwestern, where received advanced training during a post-doctoral fellowship in molecular biology during residency. He also received fellowship training in radiologic pathology at the Armed Forces Institute of Pathology, and in proton emission tomography (PET) at the University of California – Los Angeles.
Although much of his time is dedicated to clinical practice, Dr. Öz is highly involved in research. His research interests include imaging in diabetic foot infections, pathophysiology of diabetic foot infections, molecular imaging probe design and in vivo evaluation, tumor imaging and therapy in clinical trials, and investigating the mechanisms underlying hormonal regulation of bone mass and metabolism and fat metabolism. His research has resulted in numerous publications throughout his career, including the publication of a single-photon emission computed tomography (SPECT) and computed tomography (CT) based scoring system to stage the severity of foot infections in people with diabetes, a clinical trial of radiolabeled white-blood cell SPECT/CT versus MR, opportunistic CT for bone mass assessment in patients receiving PET/CT, and guidelines for diagnosis and treatment of foot infection in patients with diabetes and foot infection.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to [email protected]. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - Free!
- Clinician Member - Free!
- Technologist Member - Free!
- Resident/Student/Fellow/Retired Membership - Free!
- MOC Only - Free!
- Community Member - $35
- Professional Member - Free!
- More Information
-
Both ACCME and ASRT Credits
Expires 11/15/2027: In the first half of this session we will discuss the role of menopausal hormone replacement therapy (HRT) in bone health and fracture prevention, highlighting the significant morbidity and mortality associated with osteoporotic fractures. The presentation reviews evidence supporting fracture risk reduction with estrogen-based therapies and outlines key safety considerations that guide appropriate patient selection. In the second part of the session, we will evaluate the role of bone biopsy in the management of metabolic bone disease. It will focus on how biopsy is done, what information it provides, and how it can be implemented in the management of bone disease. The talk will explore important areas of bone management like management in patients with kidney disease, abnormalities of bone turnover and patients who have failed therapies.
Activity approved for 1.00 AMA PRA Category 1 Credits™
Activity approved for 1.5 ASRT Category A Credits
Activity Expires November 15, 2027Activity Description
In the first half of this session we will discuss the role of menopausal hormone replacement therapy (HRT) in bone health and fracture prevention, highlighting the significant morbidity and mortality associated with osteoporotic fractures. The presentation reviews evidence supporting fracture risk reduction with estrogen-based therapies and outlines key safety considerations that guide appropriate patient selection. In the second part of the session, we will evaluate the role of bone biopsy in the management of metabolic bone disease. It will focus on how biopsy is done, what information it provides, and how it can be implemented in the management of bone disease. The talk will explore important areas of bone management like management in patients with kidney disease, abnormalities of bone turnover and patients who have failed therapies.
Learning Objectives
- Understand the impact of hormone replacement therapy (HRT) on fracture risk
- Discuss the indications for HRT (prevention of fractures vs. treatment of fractures)
- Discuss the contraindications for use of HRT for fracture risk reduction
- Discuss indications for bone biopsy in patients with CKD and bone disease
- Discuss the procedure and risks/benefits
- Work through a few cases in which biopsy may have changed therapy
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASRT Credit Designation
This activity has been approved by ASRT for 1.5 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on November 15th, 2026.
$i++ ?>Sherri-Ann Burnett-Bowie, MD, MPH
Physician, Associate Professor of Medicine
Massachusetts General Hospital, Harvard Medical School
Sherri-Ann M. Burnett-Bowie MD, MPH is an Associate Professor of Medicine at Harvard Medical School and a clinical investigator in the Massachusetts General Hospital Endocrine Unit, where her research focuses on the epidemiology of menopause and clinical trials of treatments for osteoporosis. She cares for patients seen at the Mass General Endocrine Associates and the Mass General Bone Density Center. Dr. Burnett-Bowie has received multiple awards to support her clinical investigation in mineral physiology and osteoporosis, and to acknowledge excellence in teaching, the promotion of diversity and inclusion, and mentoring.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to [email protected]. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - Free!
- Clinician Member - Free!
- Technologist Member - Free!
- Resident/Student/Fellow/Retired Membership - Free!
- MOC Only - $35
- Community Member - $35
- Professional Member - $35
- More Information
-
Both ACCME and ASRT Credits
Expires 10/14/2027: Vertebral augmentation is an effective minimally invasive treatment for patients suffering from painful osteoporotic vertebral compression fractures. This presentation will review evidence-based indications for vertebral augmentation, with emphasis on clinical and imaging factors that guide optimal patient selection. We will examine short- and long-term outcomes data, including expected pain relief, functional improvement, and possible procedural risks. Practical, case-based insights will be shared to aid in every day clinical decision-making. GLP-1 receptor agonists are now widely used for the management of diabetes and overweight/obesity. Concerns have been raised about their potential impact on skeletal muscle and bone density. This talk will look at the evidence to date regarding how this class of medication impacts bone and muscle health and will highlight future areas of investigation.
Activity approved for 1.00 AMA PRA Category 1 Credits™
Activity approved for 1.5 ASRT Category A Credits
Activity Expires October 14, 2027Activity Description
Vertebral augmentation is an effective minimally invasive treatment for patients suffering from painful osteoporotic vertebral compression fractures. This presentation will review evidence-based indications for vertebral augmentation, with emphasis on clinical and imaging factors that guide optimal patient selection. We will examine short- and long-term outcomes data, including expected pain relief, functional improvement, and possible procedural risks. Practical, case-based insights will be shared to aid in every day clinical decision-making.
GLP-1 receptor agonists are now widely used for the management of diabetes and overweight/obesity. Concerns have been raised about their potential impact on skeletal muscle and bone density. This talk will look at the evidence to date regarding how this class of medication impacts bone and muscle health and will highlight future areas of investigation.Learning Objectives
- Highlight the clinical impact of osteoporotic vertebral compression fractures (VCFs) and how they contribute to functional decline and mortality.
- Discuss inclusion criteria for vertebral augmentation to help identify candidates for referral/intervention.
- Review expected outcomes of vertebral augmentation, including effects on pain relief, functional improvement, and safety.
- Evaluate the risks, limitations, and controversies surrounding vertebral augmentation, including interpretation of existing trial data.
- Review the mechanism of action and indications for glucagon-like peptide-1 (GLP-1) receptor agonists
- Examine the impact of GLP-1s on skeletal muscle mass and function
- Examine the impact of GLP-1s on bone density and fracture risk
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASRT Credit Designation
This activity has been approved by ASRT for 1.5 Category A Continuing Education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on October 15th, 2026.
$i++ ?>Daniel J. Holzwanger, MD
Interventional Radiologist
Weill Cornell Medicine
Daniel J. Holzwanger, MD is an Interventional Radiologist and Assistant Professor of Clinical Radiology at Weill Cornell Medicine and New York-Presbyterian Hospital. He earned his medical degree from Weill Cornell Medical College and completed his Diagnostic Radiology residency at New York-Presbyterian/Weill Cornell Medical Center, where he served as Chief Resident. He subsequently completed fellowship training in Vascular and Interventional Radiology at Vanderbilt University Medical Center. His clinical practice focuses on image-guided musculoskeletal and spine interventions, including vertebral augmentation, tumor ablation, nerve ablation, and embolization therapies for pain and oncology care, with ongoing research aimed at advancing minimally invasive treatments for musculoskeletal and cancer-related pain.
$i++ ?>Shirine E. Usmani, MD, PhD, FRCPC
Assistant Professor, Clinician Investigator and Staff Physician
University of Toronto, University Health Network, Toronto ON
Dr. Shirine Usmani completed her undergraduate degree in Physiology and Pharmacology at Western University before entering the MD/PhD program, also at Western. Her PhD focused on musculoskeletal health, specifically understanding molecular mechanisms involved in bone development and osteoarthritis. Dr. Usmani then went on to complete her residency training in Internal Medicine with a sub-specialization in Endocrinology at the University of Toronto. She completed a Post-Doctoral Fellowship through Toronto's Clinician Scientist Training Program with a focus on sarcopenia and genetic regulators of muscle mass. In October 2024 she started a full-time position as a Clinician Investigator/Assistant Professor at the University Health Network (UHN)/University of Toronto. Her research focuses on clinical and translational research through the UHN Osteoporosis and Metabolic Bone clinic.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to [email protected]. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - $25
- Clinician Member - $25
- Technologist Member - $25
- Resident/Student/Fellow/Retired Membership - $25
- MOC Only - $35
- Community Member - $35
- Professional Member - $35
- More Information
-
Both ACCME and ASRT Credits
Expires 10/14/2027: Estimating fracture risk should be an integral part of bone health assessment. Multiple tools and strategies are available - some well validated, others more controversial but nonetheless potentially useful. We'll try to explore as many avenues as possible to get the fullest understanding of fracture risk for treatment recommendation. The second presentation will first review the principle behind TBS, and why it correlates with other measures of trabecular bone microarchitecture and bone strength. We will review the effects of degenerative changes, fracture and other artifacts on TBS values. We will then review how the addition of TBS can alter fracture risk assessment and highlight clinical scenarios where the addition of TBS may alter fracture risk management decisions.
Activity approved for 1.00 AMA PRA Category 1 Credits™
Activity approved for 1.25 ASRT Category A Credits
Activity Expires October 14, 2027Activity Description
Estimating fracture risk should be an integral part of bone health assessment. Multiple tools and strategies are available - some well validated, others more controversial but nonetheless potentially useful. We'll try to explore as many avenues as possible to get the fullest understanding of fracture risk for treatment recommendation. The second presentation will first review the principle behind TBS, and why it correlates with other measures of trabecular bone microarchitecture and bone strength. We will review the effects of degenerative changes, fracture and other artifacts on TBS values. We will then review how the addition of TBS can alter fracture risk assessment and highlight clinical scenarios where the addition of TBS may alter fracture risk management decisions.
Learning Objectives
- Understand the rationale(s) for risk stratification in osteoporosis
- Review some scientific aspects of commonly utilized risk stratification tools
- Appreciate some additional available resources to individualize fracture risk profiles
- Explore near-term novel approaches to risk stratification
- Understand the associations of TBS with incident hip and major osteoporotic fractures, and the practical effect measurement of TBS has on FRAX fracture prediction
- Understand the circumstances under which vertebrae may need to be removed from BMD measurement but not TBS
- Understand expected changes of TBS vs BMD with osteoporosis drug therapy
- Understand how changes in scan type and tissue thickness between current and prior DXA studies may artefactually create apparent changes in TBS measurement values
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASRT Credit Designation
This activity has been approved by ASRT for 1.25 Category A Continuing Education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on October 15th, 2026.
$i++ ?>Christopher Shuhart, MD, MHA, CCD
Instructor, Department of Family Medicine and Geriatrics Fellowship
Swedish Medical Center
Dr. Shuhart was the founder and director of the Bone Health and Osteoporosis Center at Swedish Medical Group in Seattle, Washington. He is Past-President of the International Society for Clinical Densitometry (ISCD) 2019-2020. He is a co-author on the ISCD’s 2016 publication of “Best Practices” in the Journal of Clinical Densitometry, and was Co-Chair and Executive Author for the 2019 and 2023 ISCD Position Development Conferences.
Dr. Shuhart is now retired from clinical practice but continues to be active in teaching and training of residents, fellows and APC’s.
Dr. Shuhart received his medical degree from Dartmouth Medical School in 1987, and his Masters in Health Administration from the University of Washington in 2009. He is board certified in Family Medicine since 1990.
$i++ ?>John Schousboe, MD, PhD, CCD
Health Services Researcher
HealthPartners Institute
Dr. Schousboe is a health services researcher at HealthPartners Institute and past director of the bone densitometry center of Park Nicollet Clinic, a large integrated health care delivery system the Twin Cities, Minnesota. He is a Past President of the International Society of Clinical Densitometry (ISCD) and a Fellow of the American Society of Bone and Mineral Research (ASBMR). During a 20 year research career, he has been an author on over 250 peer-reviewed publications. His contributions to science include studies of the accuracy, prevalence, clinical impact, and cost-effectiveness of vertebral fracture assessment, identification and prognostic significance of abdominal aortic calcification identification on lateral spine bone density images, trabecular bone score in older men, and associations of fractures, frailty, physical performance, sleep disturbances, and cognitive impairment with total health care costs.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to [email protected]. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - $25
- Clinician Member - $25
- Technologist Member - $25
- Resident/Student/Fellow/Retired Membership - $25
- MOC Only - $35
- Community Member - $35
- Professional Member - $35
- More Information
-
Both ACCME and ASRT Credits
Expires 11/1/2027: This session will examine barriers to accessing bone density testing from a DXA technologist's perspective, with particular attention to patient populations who may be at increased risk for poor bone health but are not routinely referred for testing under current diagnostic ordering criteria or access to general healthcare. Participants will explore population-level factors that limit access to DXA services, including geographic, logistical, and health system constraints, as well as the impact of centralized scanning models and delayed scheduling on timely diagnosis and management. The session will also provide an overview of available peripheral and alternative bone assessment technologies—such as peripheral DXA (pDXA), quantitative ultrasound (QUS), and CT-derived bone mineral density—highlighting their potential role, strengths, and limitations in supporting bone health assessment and clinical decision-making when standard DXA access is limited.
Activity approved for 1.5 ASRT Category A Credits
Activity Expires November 1, 2027Activity Description
This session will examine barriers to accessing bone density testing from a DXA technologist's perspective, with particular attention to patient populations who may be at increased risk for poor bone health but are not routinely referred for testing under current diagnostic ordering criteria or access to general healthcare. Participants will explore population-level factors that limit access to DXA services, including geographic, logistical, and health system constraints, as well as the impact of centralized scanning models and delayed scheduling on timely diagnosis and management. The session will also provide an overview of available peripheral and alternative bone assessment technologies—such as peripheral DXA (pDXA), quantitative ultrasound (QUS), and CT-derived bone mineral density—highlighting their potential role, strengths, and limitations in supporting bone health assessment and clinical decision-making when standard DXA access is limited.
Learning Objectives
- Explain population-level challenges affecting access to DXA services.
- Recognize limitations associated with centralized DXA scanning and delayed scheduling.
- Describe the advantages and limitations of peripheral and alternative bone density assessment technologies, including pDXA, QUS, and CT-derived BMD.
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.ASRT Credit Designation
This activity has been approved by ASRT for 1.5 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on October 15th, 2026.
$i++ ?>Kyla Kent, BA, CBDT
Technical Director
SAMBA Lab, Stanford University School of Medicine
Kyla Kent, BA, CBDT has been with Stanford University School of Medicine since 1991 in Adult Endocrine, Stanford Prevention Research Center and lastly as Technical Director of the Stanford Assessments of Muscle and Bone across the ages (SAMBA) Lab under the department of Pediatrics. Responsibilities include clinical facility management, protocol development, supervision of clinical staff, performance of DXA, HRpQCT, Biodex, functional strength assessments and other measures related to research conducted in the areas of childhood and adolescent bone health, bone metabolism, structural assessment, body composition, exercise, sleep, sarcopenia and healthy aging. Ms. Kent is a consultant in study design and instructor in bone density related imaging modalities for both the Palo Alto VA Hospital and Stanford Hospital, Stanford Children’s Hospital and the Stanford School of Medicine and internationally for bone mass measurement technique and analysis in growing skeletons. Ms. Kent is an active member of the International Society for Clinical Densitometry (ISCD). She joined at its beginning, did take a short hiatus and rejoined when ISCD met in San Francisco to be on the test committee. She has served on many committees over the years and currently is chair of the 2026 Tech symposium, serves on the pediatric and body composition faculties and Ask an Expert. She has served on the Facility Accreditation committee since its inception in 2011. She has acted as the Director, clinical instructor and lecturer for one of the few California certified, Limited License x-ray permit in DXA training program in Oakland, CA.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to [email protected]. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - Free!
- Clinician Member - Free!
- Technologist Member - Free!
- Resident/Student/Fellow/Retired Membership - Free!
- MOC Only - Free!
- Community Member - $35
- Professional Member - Free!
- More Information
-
Both ACCME and ASRT Credits
Expires 10/14/2027: Interactive session on the topic of optimizing the sequence of osteoporosis therapies for maximum benefit.
Activity approved for 1.00 AMA PRA Category 1 Credits™
Activity approved for 1.5 ASRT Category A Credits
Activity Expires October 14, 2027Activity Description
Interactive session on the topic of optimizing the sequence of osteoporosis therapies for maximum benefit.
Learning Objectives
- Evaluate the clinical evidence supporting the initiation of treatment with osteo-anabolic drugs rather than anti-resorptive drugs for patients at very high or imminent risk of fracture.
- Identify the pharmacological "off-sets" of different osteoporosis therapies.
- Implement effective transition protocols when moving from one therapy class to another, with a specific focus on the mandatory follow-up for denosumab and anabolic therapies.
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASRT Credit Designation
This activity has been approved by ASRT for 1.5 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on October 15th, 2026.
$i++ ?>Sabashini Ramchand, MBBS
Staff Endocrinologist
Cleveland Clinic
Dr. Sabashini Ramchand is a Staff Endocrinologist at the Cleveland Clinic and an Assistant Professor at the Lerner College of Medicine – Case Western Reserve University. As a clinician-researcher, she is an emerging leader in the field of metabolic bone disease, notably serving as the Clinical Co-Chair for the ASBMR 2023 Annual Meeting. Her primary research and clinical interests involve the optimization of medical therapies for osteoporosis, including the strategic use of combination and sequential treatment regimens, as well as the optimization of skeletal health in patients experiencing bone loss due to breast cancer treatments. Dr. Ramchand completed her medical training and endocrine fellowship in Melbourne, Australia, and then transitioned to a research fellowship at Massachusetts General Hospital, Harvard Medical School before she joined the Cleveland Clinic in 2024.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to [email protected]. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - Free!
- Clinician Member - Free!
- Technologist Member - Free!
- Resident/Student/Fellow/Retired Membership - Free!
- MOC Only - $35
- Community Member - $35
- Professional Member - $35
- More Information
-
Both ACCME and ASRT Credits
Expires 9/14/2027: Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD) is a complex disorder of bone and mineral metabolism that affects all patients with CKD, in particular as kidney dysfunction worsens. CKD-MBD is associated with abnormalities in the Vitamin D-Parathyroid axis and Osteoporosis. This session will review the epidemiology of CKD-MBD and its complications and strategies to diagnose and manage the disorder, with a focus on patient-centered outcomes.
Activity approved for 1.00 AMA PRA Category 1 Credits™
Activity approved for 1.00 ASRT Category A Credits
Activity Expires September 14, 2027Activity Description
Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD) is a complex disorder of bone and mineral metabolism that affects all patients with CKD, in particular as kidney dysfunction worsens. CKD-MBD is associated with abnormalities in the Vitamin D-Parathyroid axis and Osteoporosis. This session will review the epidemiology of CKD-MBD and its complications and strategies to diagnose and manage the disorder, with a focus on patient-centered outcomes.
Learning Objectives
- Appreciate new definition of CKD-MBD
- Understand CKD-MBD from a patient-oriented perspective
- Learn a basic treatment approached to CKD-MBD
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credit(s)™
Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASRT Credit Designation
This activity has been approved by ASRT for 1.00 Category A Continuing Education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on September 15th, 2026.
$i++ ?>Thomas L. Nickolas, MD, MS, FASN, FASBMR
Chief, David C. and Betty Farrell Professor of Medicine
Division of Bone and Mineral Diseases, Washington University School of Medicine
Dr. Nickolas is a Professor of Medicine and Chief of the Division of Bone and Mineral Diseases at the Washington University School of Medicine in St Louis. Dr. Nickolas received his medical degree from the University of Pittsburgh School of Medicine, trained in Internal Medicine at the University of Pennsylvania and in Nephrology at Columbia University. His primary interests are in the skeletal effects of kidney diseases. His lab focuses on redefining our understanding of and approach to bone disease in adults and children with kidney failure. He uses advanced and novel methods to phenotype the characteristics of bone and mineral diseases in CKD patients.
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to [email protected]. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - $25
- Clinician Member - $25
- Technologist Member - $25
- Resident/Student/Fellow/Retired Membership - $25
- MOC Only - $35
- Community Member - $35
- Professional Member - $35
- More Information
-
ASRT Category A Credits
Expires 10/1/2027: This session will introduce DXA technologists to emerging innovations that are shaping the future of bone densitometry, with an emphasis on artificial intelligence–enabled tools and data integration. Participants will examine how AI-driven quality-control processes and automated region-of-interest detection can enhance measurement consistency, workflow efficiency, and scalability across clinical settings. The program will also examine how DXA data can be linked with large clinical and research datasets to support advanced risk prediction, longitudinal monitoring, and population-level analysis. In addition, participants will discuss key research opportunities and critical knowledge gaps that must be addressed to advance next-generation DXA technologies and inform the evolving role of the DXA technologist.
Activity approved for 1.5 ASRT Category A Credits
Activity Expires October 1, 2027Activity Description
This session will introduce DXA technologists to emerging innovations that are shaping the future of bone densitometry, with an emphasis on artificial intelligence–enabled tools and data integration. Participants will examine how AI-driven quality-control processes and automated region-of-interest detection can enhance measurement consistency, workflow efficiency, and scalability across clinical settings. The program will also examine how DXA data can be linked with large clinical and research datasets to support advanced risk prediction, longitudinal monitoring, and population-level analysis. In addition, participants will discuss key research opportunities and critical knowledge gaps that must be addressed to advance next-generation DXA technologies and inform the evolving role of the DXA technologist.
Learning Objectives
- Recognize how AI-enabled quality control and automated region-of-interest detection can improve consistency, efficiency, and scalability of DXA measurements.
- Identify how DXA data can be linked with large clinical and research datasets to support risk prediction, longitudinal monitoring, and population-level analysis.
- Identify key research opportunities and critical gaps that must be addressed to advance the next generation of bone densitometry.
Instructions
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
Registration Fees
Cancellation Policy
On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.ASRT Credit Designation
This activity has been approved by ASRT for 1.5 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on September 15th, 2026.
$i++ ?>John A. Shepherd, PhD, FAAPM, CCD
Professor/Chief Scientific Officer
University of Hawaii Cancer Center, Honolulu, HI
Dr. Shepherd is a Researcher/Professor at the University of Hawaii Cancer Center, a Fulbright Scholar, a Fellow of the American Institute for Medical and Biological Engineering (AIMBE), and a former President of the International Society for Clinical Densitometry. He received his PhD in Engineering Physics from the University of Virginia and then completed a Postdoctoral Fellowship in Biophysics at Princeton University. From there he went on to develop body composition and bone density algorithms for a major women’s health company and his patents are the basis for the accuracy of that company’s body composition algorithms. He then joined the Radiology Department of the University of California San Francisco and led his own research group for 19 years studying a wide variety of biomarkers for breast cancer, obesity and osteoporosis from medical imaging using advanced machine learning techniques. For the past 5 years, he has been with the University of Hawaii Cancer Center and is currently their Chief Scientific Officer. He also directs the UH Artificial Intelligence Precision Health Institute and the Hawaii Pacific Islands Mammography Registry. He has been continuously funded from the NIH since 2005, led 6 R01-funded studies, published over 350 peer-review publications that have been referenced over 23,000 times, and lastly is an avid surfer and island ridge hiker!
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to [email protected]. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
-
Register
- Non-Member - $35
- Full Member - $25
- Clinician Member - $25
- Technologist Member - $25
- Resident/Student/Fellow/Retired Membership - $25
- MOC Only - $35
- Community Member - $35
- Professional Member - $35
- More Information